Minneapolis, MN, June 06, 2025 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQB: PETV; OTCPINK: PETVW), an emerging biomedical device company focused on animal health, today announced a strategic ...
Earnings call PetVivo reported Q2 FY2026 revenue of $303K, up 51% YoY and marking its best Q2 on record. Gross margin declined due to product mix shift, but operating loss improved. Management ...
PetVivo Holdings Inc. reported a robust second quarter for fiscal year 2026, with significant increases in revenue and strategic market expansions. Despite a net loss, the company’s innovative product ...
The partnership centers on the clinical use and promotion of SPRYNG ® with OsteoCushion ® Technology, PetVivo’s cutting-edge intra-articular device designed to support joint health and durability, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback